Hormonal Health: Tips for Optimal DHEA Levels

Understanding hormonal health and DHEA is essential for enhancing well-being and managing hormonal changes effectively.

Abstract: A Comprehensive Guide to Modern Hormone Optimization

Welcome to this in-depth educational post, where I, Dr. Alexander Jimenez, will share the latest findings in hormonal health from leading researchers in the field. As a practitioner holding the titles of Doctor of Chiropractic (DC) and board-certified Family Nurse Practitioner (FNP-BC), I am passionate about integrating modern, evidence-based research with hands-on clinical experience to achieve optimal patient outcomes. This post is designed to move beyond the surface-level discussions often found in hormone therapy training and delve into the complex, interconnected web of systems that govern our well-being. My journey, alongside esteemed colleagues like Dr. Smith and Dr. Keith, has been one of continuous learning over decades, piecing together a comprehensive map to navigate the nuances of patient care. This map wasn’t available when we began. We will explore the critical, often-overlooked players in hormone balance, such as the profound influence of Vitamin D on hormone receptor sensitivity and the pivotal role of Sex Hormone Binding Globulin (SHBG). We will demystify SHBG, explaining why chasing a lower number is often a misguided strategy and how a low level can be an early predictive marker for metabolic syndrome, long before an A1C becomes elevated.

This discussion will then pivot to one of the most common and frequently misunderstood endocrine disorders affecting women today: Polycystic Ovary Syndrome (PCOS). We will reframe PCOS not merely as an ovarian issue but as a systemic condition with its roots deeply embedded in gut dysbiosis and insulin resistance. I will break down the Rotterdam criteria for diagnosis and illuminate the underlying pathophysiology, explaining how hyperinsulinemia drives hyperandrogenism and disrupts the delicate hormonal cascade. We will cover comprehensive treatment strategies that go beyond mere symptom management, focusing on addressing root causes through diet, targeted supplementation such as specific probiotics, and the judicious use of medications such as metformin and GLP-1 agonists. We’ll also discuss how to safely implement testosterone therapy in these sensitive patients, emphasizing a “start low, go slow” approach to avoid androgenic side effects.

Furthermore, we will tackle the critical topic of Prostate-Specific Antigen (PSA) monitoring in men undergoing Testosterone Replacement Therapy (TRT). The guidelines and our understanding of PSA have evolved significantly, and clinicians must stay up to date. I will explain the crucial difference between total PSA and percent-free PSA, highlighting how the latter provides a much higher sensitivity for detecting clinically significant prostate issues and can help prevent unnecessary and invasive biopsies. We will examine real-world lab results and discuss the importance of monitoring the velocity of change in PSA levels as a key risk indicator. Finally, we will shine a spotlight on Dehydroepiandrosterone (DHEA), a neurosteroid that is far more than just a simple precursor hormone. We will uncover its unique and independent actions within the central nervous system, its profound immunomodulatory and anti-inflammatory effects, and its critical role in mood, cognitive function, and overall vitality. I will provide clear, actionable guidance on optimal dosing, lab value targets, and how supplementing with DHEA can be the missing piece of the puzzle for patients who, despite optimized testosterone and thyroid levels, still don’t feel their best. This post is a culmination of years of clinical observation, research, and a commitment to providing a truly holistic and effective approach to hormone optimization.

My Journey into a Deeper Understanding of Hormonal Health

It’s a privilege to share my insights with you today. My journey in hormone optimization began over 16 years ago, and it has been a path of continuous discovery, shaped by both scientific research and, most importantly, the real-world experiences of my patients. When I first started my training, as with many practitioners, it was foundational but incomplete. I learned the mechanics—the “how-to” of hormone delivery, like testosterone pelleting—but the true education came in the years that followed. It came from navigating complex cases: patients with “perfect” serum levels on paper yet still felt unwell, those experiencing unexpected side effects, and those who weren’t responding as predicted.

This is where the real work began. It became clear that hormones do not operate in a vacuum. I started to see the profound interplay between different systems. I realized how intricately thyroid function is woven into hormonal balance, how critical Vitamin D is for hormone receptor activity, and how gut health can be the root cause of systemic hormonal dysregulation. Many practitioners attend trainings that teach them the basics of pellet insertion, but they miss the vast, intricate conversation happening within the body. My goal, alongside my esteemed colleagues Dr. Smith and Dr. Keith, has been to map out this complex territory for you. We’ve spent decades piecing this together because no one taught us how to manage these nuanced patient issues when we started. We had to learn by observing, researching, and meticulously connecting the dots.

The Vitamin D Connection: A Clinical Revelation

I want to share a story that crystallizes the importance of this holistic view. I had a patient, a woman I had been treating for many years with hormone pellets. She came into my office one day, frustrated and disheartened. “Dr. Jimenez,” she said, “I just don’t think these pellets are working anymore. I don’t feel like I did before. The mental clarity isn’t there, my energy is low, nothing has changed.”

I reviewed her case, and we confirmed her dosing and her lab levels, which were in the optimal range. As we talked, I asked her about her supplement routine. It turned out she had stopped taking her Vitamin D. A lightbulb went off. We know from extensive research that Vitamin D is not just a vitamin; it’s a steroid hormone that plays a crucial role in regulating gene expression, including the genes that control our hormone receptors. Without adequate Vitamin D, hormone receptors can become less sensitive. The hormones might be present in the bloodstream, but the cells can’t “hear” their message effectively.

I made a deal with her. “Look,” I said, “I want you to start taking your Vitamin D diligently every single day. If you come back for your next appointment in three or four months and you don’t feel a significant difference, I will personally refund the cost of your treatment.” She was intrigued and agreed to the challenge.

Three and a half months later, she returned to my clinic with a smile. “I almost don’t want to admit it because I’d love to have that refund,” she laughed, “but I will never, ever stop taking my Vitamin D again.” The change was that dramatic. This experience was a powerful reminder that we must build a solid foundation for health before and during any hormone therapy. It’s not just about the hormones themselves; it’s about the entire biochemical environment. This is why I emphasize all these interconnected pieces—we are building a foundation that supports the success of the entire therapeutic strategy.

Decoding Sex Hormone Binding Globulin (SHBG)

One of the most frequent questions I receive concerns Sex Hormone Binding Globulin (SHBG). Many practitioners and patients see a high SHBG level and immediately ask, “How do I lower it?” This question stems from a basic understanding that SHBG binds to testosterone, reducing the amount of “free” or bioavailable testosterone. While this is true, the impulse to artificially lower SHBG is often misguided and overlooks its vital role as a health marker.

The Problem with Artificially Lowering SHBG

SHBG is a protein produced primarily in the liver. Its job is to transport hormones, particularly testosterone and estradiol, through the bloodstream. When SHBG is high, it can indeed bind up a significant portion of testosterone, leading to symptoms of low T even when total testosterone levels appear adequate. However, we don’t want to force this number down.

In my clinical practice, and as supported by a growing body of evidence, I’ve observed that low SHBG is often a canary in the coal mine for metabolic disease. It is frequently seen in individuals with insulin resistance and metabolic syndrome. In fact, leading researchers have published numerous studies showing that a downward trend in SHBG levels can be a predictive marker of impending metabolic dysfunction, often appearing long before traditional markers like Hemoglobin A1c (HbA1c) become elevated. When we see a low SHBG, it prompts us to investigate the patient’s metabolic health more deeply.

Conversely, a higher SHBG level is often associated with a healthier metabolic profile. So, our goal is not to lower SHBG itself. Our goal is to overcome its binding effect to ensure the patient has enough free testosterone to feel well.

How to Overcome a High SHBG

Several factors can cause SHBG to rise. These include:

• Oral Estrogen Therapy: Oral estrogens pass through the liver, signaling it to produce more SHBG.
• Certain Medications: Some prescription drugs can increase SHBG levels.
• Low Body Weight: Very thin individuals often have higher SHBG levels.
• Excessive Alcohol Consumption: Chronic or heavy alcohol use can increase SHBG.
• Hyperthyroidism: An overactive thyroid can also lead to elevated levels.

So, how do we manage a patient with high SHBG who is symptomatic for low testosterone? The strategy is two-fold:

1. Increase the Testosterone Dose: The most direct approach is to provide enough testosterone to saturate SHBG while leaving an adequate amount of free testosterone available to tissues. We essentially “outrun” the binding capacity of the SHBG. This is why when you look at my own lab work, which I use to test these protocols, you might see a total testosterone level that seems quite high. This is a deliberate strategy to ensure my free testosterone remains in the optimal range despite my naturally higher SHBG.
2. Utilize Specific Nutrients: Certain supplements have been shown to help modulate hormone metabolism and improve the free-to-total testosterone ratio. I have personally used and studied a supplement formulation containing Shilajit and Diindolylmethane (DIM). Shilajit, a substance found in the Himalayas, has been shown in some studies to support free testosterone levels. DIM helps promote healthy estrogen metabolism, which can indirectly influence the hormonal environment. On this protocol, I was able to double my free testosterone levels right before my next pellet insertion, confirming its efficacy in my own body. I never recommend a protocol to my patients that I haven’t thoroughly vetted and often tried myself.

SHBG as a Predictive Health Marker

The clinical utility of SHBG as a biomarker is gaining significant traction in the research community. Studies are consistently demonstrating its power as a predictive tool.

• One major study found that in women, those with SHBG levels at the higher end of the normal range had an 80% lower risk of developing insulin resistance.
• In men, a lower SHBG was strongly correlated with an increased risk of metabolic syndrome.
• Researchers are now looking at SHBG as an incredibly predictive factor for long-term health outcomes. Low SHBG is being linked to increased all-cause mortality, as well as higher risks for specific cardiovascular events and cancers.

As a clinician, I find this information invaluable. When I see a lab report, the SHBG value tells me a story. A patient with a robust SHBG level in the upper third of the reference range is likely living a healthier lifestyle and has a better metabolic foundation. A patient with a low SHBG, even if they aren’t overweight, is someone I will immediately screen more closely for insulin resistance and other metabolic issues. Understanding this correlation allows us to be proactive, not just reactive, in our patient care.

A Deeper Dive into Polycystic Ovary Syndrome (PCOS)

Dr. Smith laid a beautiful foundation for this topic, and I want to expand on it because PCOS is one of the most common, yet widely misunderstood and misdiagnosed, endocrine disorders in women of reproductive age. You will inevitably see these patients in your practice, whether you seek them out or not, because their symptoms often mimic those of general hormonal imbalance, leading them to seek help for what they believe are low hormone levels.

The True Root Cause: Gut Dysbiosis and Insulin Resistance

The traditional view of PCOS as a primary ovarian problem is outdated and incomplete. While cystic ovaries can be a feature of the syndrome, they are a symptom rather than the root cause. Cutting-edge research, which I have followed closely, is now pointing definitively to gut dysbiosis as the foundational trigger for PCOS.

When you peel back the layers of the onion, you find that an imbalanced gut microbiome—gut dysbiosis—leads to increased intestinal permeability (often called “leaky gut”). This allows inflammatory molecules such as lipopolysaccharides (LPS) to enter the bloodstream, triggering chronic, low-grade systemic inflammation. This inflammation is a primary driver of insulin resistance.

The body’s cells become “numb” to insulin’s signal. In response, the pancreas releases even more insulin, leading to hyperinsulinemia (chronically high insulin levels). This is the central domino that falls, setting off the entire hormonal cascade of PCOS:

1. Hyperinsulinemia stimulates the ovaries to produce an excess of androgens, primarily testosterone. This is known as hyperandrogenism.
2. Hyperinsulinemia signals the liver to reduce SHBG production. This results in a higher proportion of the already elevated testosterone being in its free, biologically active form, which exacerbates symptoms.
3. Hyperinsulinemia disrupts the signaling in the brain, leading to an altered release of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH). Typically, we see a”flipped” LH: FSH ratio, where LH is two to three times higher than FSH. This imbalance prevents proper follicle development and maturation, leading to anovulation (lack of ovulation) and menstrual irregularities.

So, to be clear: PCOS is not fundamentally an ovarian issue. It is a systemic, metabolic, and inflammatory disorder originating from the gut.

Diagnosis and Presentation: Beyond the Classic Triad

The diagnosis of PCOS can be tricky because the presentation is so heterogeneous. The classic triad of obesity, hirsutism (excess male-pattern hair growth), and amenorrhea (absent periods) is present in only a fraction of cases. In my clinical experience, I’ve seen that up to 50% of women with PCOS are not overweight. Many do not have the telltale ” string of pearls” cysts on their ovaries that are visible on ultrasound.

This has led to the development of different phenotypes of the syndrome. We now recognize “lean PCOS” and “PCOS-like syndrome,” where patients exhibit all the metabolic and androgenic symptoms without the presence of ovarian cysts.

The most widely accepted diagnostic criteria are the Rotterdam Criteria, which require a patient to meet two of the following three conditions:

1. Oligo-ovulation or anovulation: Infrequent or absent ovulation, which typically manifests as irregular menstrual cycles.
2. Clinical or biochemical signs of hyperandrogenism:

• Clinical signs: Hirsutism, severe acne, or androgenic alopecia (male-pattern hair loss).
• Biochemical signs: Elevated levels of total or free testosterone or other androgens like DHEA-S.

• Polycystic ovaries on ultrasound: The presence of 12 or more small follicles on an ovary.

It’s critical to note that abnormalities in insulin signaling precede the development of hyperandrogenism. This is a key insight for treatment.

The PCOS Patient in Your Clinic: What to Look For

A woman with undiagnosed PCOS might present to your clinic complaining of fatigue, anxiety, low libido, and weight gain. You run her initial hormone panel. Her total testosterone might come back on the low-to-normal end, perhaps in the 20s or 30s ng/dL. However, when you look at her free testosterone, you may be surprised to find it at the upper end of the reference range, or even above it. This discrepancy—low/normal total T with high-normal/high free T—is a classic biochemical signature of PCOS, driven by that low SHBG. This patient is a prime example of someone who is androgen-sensitive and requires a very cautious approach.

A Comprehensive Treatment Protocol for PCOS

Treating PCOS effectively requires a multi-pronged approach that addresses the root causes, not just the downstream symptoms. Simply prescribing birth control pills or spironolactone is like putting a bandage on a deep wound. It may manage some symptoms, but it does nothing to correct the underlying metabolic and inflammatory dysfunction.

1. Fix the Gut and Address Inflammation

This is the foundational step. You don’t have to become a gastroenterologist, but you must address the basics.

• Dietary Interventions: Encourage an anti-inflammatory diet, low in processed foods, sugar, and refined carbohydrates. A Mediterranean-style or whole-foods diet is an excellent starting point.
• Probiotics: A high-quality, multi-strain probiotic is non-negotiable. It helps to restore balance to the gut microbiome, reduce intestinal permeability, and lower inflammation. Dr. Smith mentioned a new formulation called Avexin GL Pro, which our nutrition expert, Elizabeth DeMayo, has lectured on. It is a robust, well-formulated probiotic that I highly recommend because it contains specific strains shown to be beneficial for metabolic health.
• Lifestyle: Ensure the patient has regular bowel movements. Simple as it sounds, this is a cornerstone of detoxification. Intermittent fasting can also be a powerful tool for improving insulin sensitivity.

2. Target Insulin Resistance

This is the central pillar of PCOS management.

• Metformin: This has long been a mainstay treatment. However, to truly impact insulin resistance in PCOS, patients often need to reach a dose of 2,000 mg per day. This can be difficult due to gastrointestinal side effects. The key is a slow titration. I start my patients on 500 mg of the extended-release (ER) version at night with food. After a week or two, as they tolerate it, we add a second 500 mg dose in the morning. We continue this gradual escalation until they reach 1,000 mg twice daily. This slow process allows the gut to adapt and significantly improves compliance.
• GLP-1 Receptor Agonists: Medications like Semaglutide (Ozempic/Wegovy) and Tirzepatide (Mounjaro/Zepbound) are game-changers for PCOS, especially in patients with comorbid obesity. They are incredibly effective at improving insulin sensitivity, promoting weight loss, and subsequently lowering androgen levels. When you correct the hyperinsulinemia with these agents, the liver begins to produce more SHBG, which binds up the excess free testosterone. We often see androgen levels decrease by up to 80%. This leads to improvement in hirsutism and acne, restoration of menstrual cycles, and even a return of fertility. However, these improvements take time. Restoring ovulation and regular cycles can take up to three years of consistent treatment.

3. Manage Androgenic Symptoms

While we work on the root causes, patients need relief from distressing symptoms like hirsutism and acne.

• Spironolactone (Aldactone): This medication is a potent androgen blocker. For PCOS, this is one of the only times I will recommend a dose of 100 mg per day. At this dose, it effectively blocks testosterone’s effects at the hair follicle and sebaceous gland, reducing hair growth and acne. It’s important to note that for a non-PCOS patient (e.g., a postmenopausal woman on pellets experiencing minor hair shedding), I would never exceed 50 mg, as it would block the beneficial effects of the testosterone therapy. In PCOS, however, the higher dose is necessary and beneficial. It’s also important to counsel patients that it can take 6 to 12 months to see a significant improvement in hair-related symptoms.

4. Optimize Thyroid and Progesterone

• Thyroid: PCOS patients are frequently suboptimal in their thyroid function. Optimizing their thyroid with a focus on achieving an ideal Free T3 level is crucial for overall metabolic rate and energy.
• Progesterone: These women are almost universally deficient in progesterone. This is a direct result of their anovulatory cycles (progesterone is produced by the corpus luteum after ovulation). This deficiency is a primary reason for the high rate of miscarriage in PCOS patients who do conceive. Progesterone is the “pro-gestation” hormone; it is essential to prepare the uterine lining and sustain a pregnancy. Whether they are trying to conceive or not, these patients benefit from progesterone replacement. I typically use oral micronized progesterone, starting at 200 mg at bedtime. For those trying to carry a pregnancy, we may need higher doses, sometimes 200 mg at night and another 100 mg during the day, to maintain a serum progesterone level above 20 ng/mL, with an optimal target around 24 ng/mL.

5. Testosterone Pelleting in PCOS Patients: A Cautious Approach

What if you have a patient who looks like PCOS, has the metabolic markers, and you’ve determined she could benefit from the steady-state hormone levels provided by pellets? You must proceed with extreme caution. These patients are highly sensitive to androgens. Their low SHBG means that any testosterone you introduce will result in a rapid and significant spike in free testosterone. If you use a standard dose, you risk causing severe acne, hirsutism, and virilization.

The rule is to start low and go slow. The dosing software we use includes a feature that lets you indicate whether a patient has PCOS or is insulin resistant. It will automatically adjust the recommended starting dose downwards. I would not start a suspected PCOS patient with more than 87.5 mg of testosterone. You can always add more at a later date, but you can’t take it away once it’s implanted. Observe how they respond to the low dose first before considering any increase.

Becoming knowledgeable in PCOS will set you apart. These patients are actively seeking help and are very connected in online communities. When you help one, word will spread, and you will become known as a practitioner who truly understands their condition.

Navigating PSA Levels in Men on Testosterone Therapy

Another critical area of management that every hormone provider must master is the monitoring of Prostate-Specific Antigen (PSA) in male patients. The guidelines and our understanding have evolved significantly, and it’s vital to move beyond the old, simplistic view that testosterone causes prostate cancer (a myth that has been thoroughly debunked) and adopt a more nuanced, evidence-based approach to screening.

Modern PSA Testing Guidelines

The American Urological Association (AUA) provides guidelines that serve as a good starting point:

• Ages 40-54: Annual PSA screening is recommended for men in high-risk populations (e.g., African American men, men with a strong family history of prostate cancer).
• Age 55 and older: Annual screening is generally recommended for all men, especially if they are considering or are currently on Testosterone Replacement Therapy (TRT).

However, simply looking at the total PSA number is not enough. This is where many practitioners fall short.

The Critical Importance of Percent-Free PSA

The most important takeaway I want you to have regarding PSA is the value of the percent-free PSA. Total PSA is a protein produced by the prostate gland. It can be elevated for many reasons other than cancer, including:

• Benign Prostatic Hyperplasia (BPH)
• Prostatitis (inflammation/infection of the prostate)
• Recent ejaculation or sexual activity
• Prostate massage or even a long bicycle ride

Because of this, total PSA is a test with low sensitivity for prostate cancer. Many men with elevated total PSA are sent for unnecessary, painful, and risky biopsies.

Free PSA is the portion of PSA that is not bound to other proteins in the blood. Research has shown that in men with prostate cancer, a higher proportion of their PSA is bound, leaving a lower percentage free. Therefore, a lower percent-free PSA is a much more concerning sign than a high total PSA alone. Percent-free PSA gives the test a much higher sensitivity.

How to Implement and Interpret Percent-Free PSA

In my practice, and what I recommend for all clinicians, is to set up an automatic reflex for percent-free PSA. I have standing orders with my lab partners (like Quest, Labcorp, and others) that if any male patient’s total PSA comes back at 4.0 ng/mL or higher, the lab automatically runs the percent-free PSA on the same sample. This saves time and ensures I get the crucial data I need without a second blood draw. You can easily arrange this with your own lab representative.

Here’s how to interpret the results, based on established literature:

• Percent-Free PSA > 25%: Very low likelihood of cancer. We can be comfortable monitoring this patient and rechecking in 3-6 months.
• Percent-Free PSA 10-25%: Intermediate likelihood. The elevation could be from BPH or prostatitis. We might consider a course of antibiotics if they are symptomatic for prostatitis and then recheck.
• Percent-Free PSA < 10%: High likelihood of clinically significant prostate cancer. This is a red flag that requires further investigation.

Let me show you a real-world example. I had a 58-year-old patient whose total PSA came back at 5.0 ng/mL. The reflex test was run, and his percent-free PSA was 10%. The lab report itself provides a risk stratification chart. For a man his age with a percent-free PSA of 10%, it indicated a 56% probability of prostate cancer. This is a powerful visual tool to show the patient and explain why a referral is necessary. Without the free PSA data, another clinician might have dismissed the 5.0 as “borderline” and rechecked it later, potentially delaying a crucial diagnosis.

Conversely, I had another patient whose total PSA came back at 5.9 ng/mL, but his percent-free PSA was 28%. I was very comfortable not referring him for an immediate biopsy and instead chose to monitor him, as the high percentage of free PSA suggested a benign cause.

The Next Step: Prostate MRI

If you have a patient with a concerning PSA profile (e.g., total PSA > 4.0 and percent-free PSA < 10%), what is the next step? Historically, this would mean an immediate referral to a urologist for a transrectal ultrasound (TRUS) guided biopsy.

However, the gold standard for prostate imaging today is multiparametric prostate MRI. An MRI is non-invasive, more comfortable for the patient, and provides vastly superior detail. It can accurately detect, locate, and measure suspicious lesions within the prostate. Radiologists use a scoring system (PI-RADS) to classify the likelihood of cancer. An MRI can save countless men from unnecessary biopsies. Furthermore, the radiologist’s report will identify and describe benign conditions such as BPH or signs of acute or chronic prostatitis, which can help explain the elevated PSA. If you have access to a facility with a radiologist experienced in reading prostate MRIs, this should be your first choice for investigation before referring for a biopsy.

The Unsung Hero: Understanding DHEA

I want to conclude our deep dive by discussing a critically important hormone yet often overlooked: Dehydroepiandrosterone, or DHEA. For a long time, DHEA was thought of simply as a weak adrenal androgen and a precursor hormone that could be converted downstream into testosterone and estrogens. While it does serve that function, we now know it is so much more.

DHEA: A Potent Neurosteroid

Modern research has revealed that DHEA is a potent neurosteroid with its own unique receptors in the brain and central nervous system. It is synthesized independently in the brain, separate from the adrenal glands. This is a paradigm-shifting discovery. Remember our core principle: if a cell has a receptor for a molecule, it means that cell needs that molecule to function optimally. The brain needs DHEA.

Just like testosterone and other vital hormones, DHEA production follows a predictable age-related decline. It peaks in our mid-20s and then begins a steady drop. By the time we are 70, our DHEA levels may be only 10-20% of what they were in our youth. This decline has profound physiological consequences.

The Multifaceted Benefits of DHEA Optimization

When DHEA levels are low, patients present with symptoms that can easily be mistaken for low testosterone or hypothyroidism: fatigue, depression, anxiety, low libido, joint pain, poor memory, and decreased sense of well-being. I have seen countless cases, particularly among my female patients, in which we have optimized their testosterone, estrogen, and thyroid levels. Yet, they still complain of low mood and a lack of vitality. In 99% of these cases, when I check their DHEA levels, they are in the basement.

Optimizing DHEA levels to the upper quartile of the young adult reference range is associated with a remarkable array of benefits supported by scientific literature:

• Improved Mood and Well-being: DHEA has powerful antidepressant and anti-anxiety effects. It attenuates cognitive decline and improves psychological well-being.
• Immunomodulation: DHEA directly affects the immune system, influencing the activity of Natural Killer (NK) cells and T cells. It is a potent anti-inflammatory agent. One fascinating study showed it induced remission in patients with inflammatory bowel disease.
• Metabolic and Cardiovascular Health: Low DHEA is an independent predictor of cardiovascular mortality. Optimizing DHEA improves endothelial function, helps manage cholesterol levels, and supports overall heart health.
• Musculoskeletal Health: It improves muscle strength, bone density, and skin health.
• The Cortisol Connection: DHEA and cortisol have an inverse relationship. They are both produced in the adrenal glands and compete for the same precursor pathways. When chronic stress drives cortisol levels high, DHEA production suffers. Conversely, supplementing with DHEA can help to buffer the negative effects of high cortisol. A clinical pearl I’ve observed is that for patients struggling with stubborn central adiposity (belly fat) despite being on TRT and GLP-1s, adding in DHEA can be the key to finally shifting their body composition by helping to lower the cortisol burden.

Dosing and Monitoring DHEA

When you test for DHEA, you should order DHEA-Sulfate (DHEA-S), as it is the more stable form in the bloodstream and provides a more accurate reflection of your body’s reserves. The lab reference ranges are incredibly wide (e.g., 60 to 400 µg/dL) because they reflect the entire aging population. This is not an optimal range; it’s an expected range for a generally sick population.

Based on outcome studies, our therapeutic target should be the upper quartile of the young adult reference range.

• For women, I aim for a level between 200 and 250 µg/dL.
• For men, the target is generally between 350 and 450 µg/dL.

I prefer to use micronized, pharmaceutical-grade DHEA from a compounding pharmacy to ensure purity and accurate dosing.

• Typical starting dose for women: 10-15 mg per day.
• Typical starting dose for men: 25-50 mg per day.

If using over-the-counter supplements, you may need higher doses, but the quality can be inconsistent. The primary side effect is related to androgen conversion, which can sometimes cause acne, especially in sensitive individuals. For this reason, I am cautious about using it in PCOS patients who are already dealing with hyperandrogenism.

For men and postmenopausal women who may not want to use testosterone or cannot for some reason, DHEA is an excellent option. It can provide significant improvements in energy, mood, and libido. In my clinical practice, I have found that for women who are difficult to pellet or who are sensitive to every minor side effect, optimizing their DHEA can be a game-changer. DHEA has a greater propensity to convert to DHT, the main libido-driving metabolite, than pellet therapy does in some women. Layering DHEA optimization is a powerful tool in your clinical arsenal.

Summary, Conclusion, and Key Insights

Summary

This educational post, authored from my perspective as Dr. Alexander Jimenez, DC, APRN, FNP-BC, provides a deep dive into advanced concepts in hormone optimization, moving beyond foundational training to incorporate modern, evidence-based research and years of clinical observation. The discussion began by establishing the necessity of a holistic approach, using a clinical anecdote about Vitamin D’s critical role in hormone receptor sensitivity to illustrate that optimizing the body’s biochemical environment is paramount for successful therapy. We then deconstructed the complex role of Sex Hormone Binding Globulin (SHBG), reframing it from a simple obstacle to be lowered into a vital biomarker for metabolic health. The post argues against artificially lowering SHBG, noting that low SHBG levels predict insulin resistance. Instead, it advocates for overcoming its effects by sufficiently dosing testosterone and using targeted nutrients like Shilajit and DIM.

A significant portion was dedicated to Polycystic Ovary Syndrome (PCOS), re-characterizing it as a systemic inflammatory condition rooted in gut dysbiosis and hyperinsulinemia, not just an ovarian disorder. A comprehensive treatment protocol was detailed, emphasizing gut repair, aggressively treating insulin resistance with metformin or GLP-1 agonists, managing androgenic symptoms with appropriate doses of spironolactone, and optimizing thyroid and progesterone levels. The post also provided critical guidance on cautiously administering testosterone therapy to this sensitive patient population. The focus then shifted to male health, specifically the updated interpretation of Prostate-Specific Antigen (PSA) levels. The crucial diagnostic value of percent-free PSA was highlighted as a tool to increase screening sensitivity and avoid unnecessary biopsies, with the multi-parametric prostate MRI presented as the modern gold standard for investigation. Finally, the post championed the often-underestimated role of Dehydroepiandrosterone (DHEA), explaining its function as a potent neurosteroid with unique receptors and actions in the brain. We explored its immunomodulatory, anti-inflammatory, and mood-regulating benefits, its inverse relationship with cortisol, and provided clear targets and dosing strategies for its optimization.

Conclusion

The practice of hormone optimization is a dynamic, evolving field that demands more than a superficial understanding of hormone replacement therapy. The insights presented on January 16, 2026, reflect a synthesis of cutting-edge research and extensive clinical experience, emphasizing that true patient success lies in a comprehensive, systems-based approach. We must look beyond the hormones themselves to the foundational pillars that support their function: nutrient status, gut health, metabolic function, and inflammation. By understanding the nuanced roles of biomarkers like SHBG, correctly diagnosing and treating the root causes of complex syndromes like PCOS, employing advanced screening methods like percent-free PSA, and recognizing the profound impact of neurosteroids like DHEA, we as clinicians can elevate our practice. This allows us to move from simply replacing numbers on a lab report to truly restoring vitality, function, and quality of life for our patients. This deeper knowledge empowers us to create personalized, effective, and safe therapeutic strategies that address the whole person, leading to lasting and meaningful health outcomes.

Key Insights

• Foundational Health is Paramount: Hormone therapy is most effective when built upon a solid foundation of nutrient sufficiency (e.g., Vitamin D for receptor sensitivity) and overall systemic health.
• SHBG is a Health Metric, Not an Enemy: A low SHBG is an early warning sign for metabolic syndrome. The goal is not to lower a high SHBG but to overcome its binding capacity with adequate testosterone dosing and supportive nutrients.
• PCOS is a Gut-Driven Metabolic Disease: Its root cause is gut dysbiosis, which leads to inflammation and insulin resistance. Effective treatment must target these core issues, not just the downstream hormonal symptoms.
• Percent-Free PSA is a Superior Screening Tool: Relying on total PSA alone is insufficient. Utilizing the percent-free PSA reflex test dramatically improves the accuracy of prostate cancer screening and helps prevent unnecessary invasive procedures. The prostate MRI is the preferred next step for investigation.
• DHEA is a Critical Neurosteroid: It is not just a precursor hormone; it has vital functions in the brain related to mood, cognition, and stress modulation. Optimizing DHEA to youthful levels can be the missing piece for patients who still lack vitality despite otherwise “optimized” hormones.
• Treat the Patient, Not the Paper: Lab values are a guide, but clinical presentation and patient experience are king. A deep understanding of the interconnectedness of these systems enables nuanced adjustments that can make the difference between a patient feeling “okay” and truly “optimal.”

References

• American Urological Association (AUA) Guidelines on PSA Testing. (Consult auanet.org for the most current guidelines).
• Research on SHBG as a predictor for metabolic syndrome and type 2 diabetes. (Journals such as Diabetes Care, The Journal of Clinical Endocrinology & Metabolism).
• Studies on the role of gut dysbiosis in the pathogenesis of PCOS. (Journals such as Nature Medicine, Gut, Human Reproduction Update).
• Literature on the efficacy of GLP-1 agonists and metformin in the treatment of PCOS. (The New England Journal of Medicine, Lancet Diabetes & Endocrinology).
• Clinical trials on the diagnostic accuracy of percent-free PSA vs. total PSA. (Journal of Urology, Prostate Cancer and Prostatic Diseases).
• Research on the role of multi-parametric MRI in the diagnosis of prostate cancer. (European Urology, Radiology).
• Studies on the neuroprotective and immunomodulatory effects of DHEA. (Proceedings of the National Academy of Sciences (PNAS), Journal of Neuroendocrinology).

Keywords

Hormone Optimization, Dr. Alexander Jimenez, Testosterone Replacement Therapy, Polycystic Ovary Syndrome, PCOS, Sex Hormone Binding Globulin, SHBG, Insulin Resistance, Gut Dysbiosis, Progesterone Deficiency, PSA, Percent-Free PSA, Prostate MRI, DHEA, Neurosteroid, Vitamin D, Hormone Receptor Sensitivity, Metformin, GLP-1 Agonists, Spironolactone, Functional Medicine, Evidence-Based Medicine.

Disclaimer: The information presented in this educational post is intended for informational and educational purposes only. It is a reflection of the author’s clinical experience and interpretation of the current body of medical research. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

Individual Medical Disclaimer: All individuals are unique, and medical conditions and treatment plans are highly specific to each person. You must consult with your own medical provider to obtain recommendations and treatment plans tailored to your personal health situation. Do not disregard professional medical advice or delay in seeking it because of something you have read in this post.